Recently, the medical big data industry broke a news--a professional industry fund called " Medical Big Data Application Product Incubation Fund" was established in Hangzhou. The fund focuses on the industry's SMEs, especially the venture capital and market channels. Pain points. According to the arterial network, this is the first incubator fund in China that focuses on medical big data. The medical big data industry is the region with the highest attention in the past two years. The medical imaging + artificial intelligence, structured data + machine learning, and third-party medical imaging centers are the concentrated outbreaks of the industry. However, the characteristics of the emerging industries in the medical big data industry and the high technical threshold of the industry have led to enterprises and entrepreneurs concentrated in the industry, mostly technical talents. The structure of the enterprises is also more biased towards the technical field. Market experience and capital are the whole industry. The most clear pain point. According to the news, the “Medical Big Data Application Product Incubation Fund†established in Hangzhou, Zhejiang Province was jointly initiated by Hangzhou Yingku Medical Technology Co., Ltd. (INCOOL) and Shenzhen Qianhai Medical Group Jinfu Group. The design scale of the first fund is 2 With RMB 100 million, the fund provides financial services for industry enterprises and entrepreneurs, with a focus on providing comprehensive investment, factoring, guarantees, credit loans and other financial services for hospitals, medical manufacturers and medical agents. More importantly, the fund's data clearly shows that it can provide industry companies, especially entrepreneurs, with the most urgent market channels to solve their biggest pain points in terms of technology and products but not the ability to open up markets. Through the inquiry, Hangzhou Yingku Medical Technology Co., Ltd. (INCOOL) is a medical big data enterprise with artificial intelligence technology as the core in the industry in the past two years. The company was established in just over a year and has been in the country for 20 years. More than 400 top three hospitals in other provinces started their business. Shenzhen Qianhai Medical Group Jinfu Group has invested more than 3 billion yuan in investment and credit in the medical industry every year. It is understood that Zheng Jun, the chairman of Hangzhou Yingku Medical Technology Co., Ltd. (INCOOL) has been deeply involved in the medical industry for more than 20 years. The industry includes pharmaceutical industry, technology research and development enterprises, and market sales companies. Zheng Jun accepted an interview with the Arterial Network at the company headquarters of the National High-tech Industrial Park in Binjiang District, Hangzhou. Zheng Jun said that the fund originated from being an entrepreneur who has been deeply involved in the medical industry for more than 20 years. He is well aware of the lack of funds and lack of channels in the entrepreneurial process. Therefore, helping entrepreneurs solve these problems is not only able to obtain a return on investment, but more importantly, industry development can contribute their own strength. To this end, how to provide professional services to the industry has always been his wish. Zheng Jun also introduced that medical big data is the biggest hot spot in the industry in the past two years, and Hangzhou Yingku Medical Technology Co., Ltd. (INCOOL) actually began to lay out this industry as early as 6 years ago. The entry point is artificial intelligence technology. The foundation is medical image + artificial intelligence + Internet as a breakthrough. In the course of several years of entrepreneurship, the company's current medical big data main product 3D reconstruction surgery planning system has made a big breakthrough, and artificial intelligence products will soon be introduced to the market. At the same time as these achievements, Hangzhou Yingku Medical Technology Co., Ltd. (INCOOL) felt the opportunity in the field of medical big data. Zheng Jun said that due to the tide of medical big data, many entrepreneurs began to gather in this industry. However, the status quo of the high-tech threshold in this industry determines that many entrepreneurs are technical elites, and they generally lack the ability to raise funds and market channels. The field of medical big data is the world's leading technology. If China wants to be in the medical technology field, it must increase its investment in this area. To this end, as the forerunner of the industry, he has accumulated market channels for more than 20 years. At the same time, as a former surgeon, contributing to the development of medical care is both a corporate motivation and his personal motivation. Yan Lei, chairman of Shenzhen Qianhai Medical Co., Ltd., said in an interview that he would serve China Construction Bank, China Minsheng Bank, Ping An Group and Wanda Group before starting the medical service, in order to provide professional services to the industry. Financial services are their core competence. Yan Lei said that through market research, in 2016, only the medical and device market has reached a scale of 200 billion. The medical industry has great development opportunities. For this reason, the medical partner’s clothing has been positioned to serve medical care since the day of its establishment. The financial technology service platform in the field, which has a number of companies such as factoring, private equity investment, guarantee, credit reporting, financial services, etc., mainly provides comprehensive financial services for hospitals, medical manufacturers, agents and medical consumption. As for why the fund launched this time is positioned in “Medical Big Dataâ€, Yan Lei said that how to obtain sufficient liquidity support has always been one of the core pain points of medical industry enterprises. However, the medical industry, especially the circulation enterprises, have almost no collateral, and the banking channel is more difficult. Especially for big data companies, there are technologies that are unfunded and channelless, and the medical partner Jinfu Group is able to provide specialized financial services for these companies. At the same time, in cooperation with Chinese medicine company Jinfu Group found that Hangzhou Yingku Medical Technology Co., Ltd. (INCOOL) not only establishes research and development bases at home and abroad, but also has strong technical research and development capabilities. In just one year, the 3D reconstruction of its core business of medical big data has been in the leading position in the industry, which fully demonstrates the technical capabilities and market development capabilities of Hangzhou Yingku Medical Technology Co., Ltd. (INCOOL). Financial service companies can truly serve industry companies by working with these companies with core technology capabilities and market expansion capabilities. Yan Lei said that the main direction of the fund launched this time is the incubation of medical big data application products. The core of the fund is to provide financing and market channels for startup enterprises. The main products include investment and credit. It is also understood that Hangzhou Yingku Medical Technology Co., Ltd. (INCOOL) and Shenzhen Qianhai Medical Partner Jinfu Group have established the "Medical Big Data Application Product Incubation Fund" strategy signing ceremony in Hangzhou Yingkuo Medical Technology Co., Ltd. (INCOOL) Hangzhou Headquarters. Enterprises from China Merchants Bank, Hua Xia Bank, Nanjing Bank and Langui Asset Management Co., Ltd. participated in the signing ceremony and conducted business negotiations with some participating industry companies. Vitamin A in fresh corn also has a certain auxiliary effect on the prevention and treatment of common dry eye, bronchitis, dry skin and nerve paralysis. Fresh corn is rich in lysine (very little in dry corn), which is an essential nutrient for the human body. Studies have found that eating more fresh corn can also inhibit the side effects of anticancer drugs on the human body. The cellulose in fresh corn is more and longer, and its amount is 6 to 8 times that of polished rice and flour. Fiber can make the stool smooth, so eating corn often can prevent constipation and hemorrhoids, and can also reduce the occurrence of gastrointestinal diseases. At the same time, it is also beneficial for preventing rectal cancer, arteriosclerosis, and lowering cholesterol. In addition, fresh corn is a bit hard and needs to be chewed hard when eating, which can exercise the teeth and promote saliva production and strong gums. Waxy Corn,Yellow Waxy Corn,Glutinous Corn Cob,Yellow Glutinous Corn Cob Jilin Province Argricultural Sister-in-law Food Co., Ltd. , https://www.nongsaocorn.com
